StockGlow

Cue Biopharma, Inc. (CUE)

Develops targeted immune therapies to treat allergies and autoimmune diseases.

$30.25-0.07%Healthcare
Compare CUE with
StockGlow Score
85
Bullish
BearishBullish
1 year ago+36.8%

The outlook

CUE is trading near the middle of its 52-week range, above both its 50- and 200-day moving averages. Analysts' average price target sits roughly 280% above the current price, suggesting substantial upside in their view, though such targets reflect opinions rather than guarantees. Coverage appears constructive overall.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range62% of the way from its 52-week low to high
Price targetAvg target +280% vs current price
Market cap
$127.1M
52-wk high
$45.50
52-wk low
$4.98
50-day avg
$27.87
200-day avg
$18.07
Trailing P/E
—

Similar stocks

VRCAVerrica Pharmaceuticals Inc.$5.40+2.08%STROSutro Biopharma, Inc.$23.73-1.17%CTMXCytomX Therapeutics, Inc.$3.22-0.92%FULCFulcrum Therapeutics, Inc.$3.72-0.27%MGTXMeiraGTx Holdings plc$11.82-3.90%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy